Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study

BACKGROUND: In late 2022, the SARS-CoV-2 omicron (B.1.1.529) BA.5 sublineage accounted for most of the sequenced viral genomes worldwide. Bivalent mRNA vaccines contain an ancestral SARS-CoV-2 strain component plus an updated component of the omicron BA.4 and BA.5 sublineages. Since September, 2022,...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbel, Ronen, Peretz, Alon, Sergienko, Ruslan, Friger, Michael, Beckenstein, Tanya, Duskin-Bitan, Hadar, Yaron, Shlomit, Hammerman, Ariel, Bilenko, Natalya, Netzer, Doron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156150/
https://www.ncbi.nlm.nih.gov/pubmed/37062302
http://dx.doi.org/10.1016/S1473-3099(23)00122-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156150/
https://www.ncbi.nlm.nih.gov/pubmed/37062302
http://dx.doi.org/10.1016/S1473-3099(23)00122-6

Ejemplares similares